Indeed, endogenous CD37-negative lymphoma cell lines (OciLy19 and SUDHL6) resembled the CD37KO phenotype and displayed increased ATP producing capacity and spare respiratory capacity (SRC) upon palmitate supplementation, which was abolished by an FA-metabolism inhibitor, etomoxir (Fig. S4A–I). The gene discussed is CD37; the disease is lymphoma.